Overview A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With PNH Status: Active, not recruiting Trial end date: 2021-01-30 Target enrollment: Participant gender: Summary Evaluation of the Efficacy and Safety of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria . Phase: Phase 3 Details Lead Sponsor: Apellis Pharmaceuticals, Inc.